Davita Inc vs Marsh & McLennan Companies, Inc. — how do they compare? Davita Inc trades at $179.02 (market cap $11.38B), while Marsh & McLennan Companies, Inc. trades at $191.32 (market cap $91.27B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 8× Davita Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.07% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | MRSH | |
|---|---|---|
Market Cap | $11.38B | $91.27B |
Sector | Health | Financials |
52-Week High | $240.96 | $211.21 |
52-Week Low | $103.87 | $157.32 |
Enterprise Value | $24.10B | $111.95B |
Dividend Yield | — | 2.07% |
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →